Regulatory approval risk is the prospect that a deal is blocked, delayed or forced to change by authorities whose clearance is a condition of completion: merger-control regulators, foreign-investment screeners, and sector supervisors in regulated industries. Boards care because an approval that fails or drags on can collapse the transaction, trigger break fees, or impose divestments that gut the rationale. This research note explains how approval risk presents in your chosen jurisdiction and industry, a framework for mapping required clearances and timelines, scenarios in which deals are conditioned or prohibited, the warning indicators of a problematic filing, realistic impact ranges, and mitigation, with guidance on when to engage antitrust and regulatory counsel. It is research, not legal advice.
Reference material for informed readers, not advice.
